Drug Study

GENERIC NAME: HRZE

(isoniazid+rifampicin+pyrazinamide+ethambutol)
Brand name: Myrin
Dosage: 3 tab 30 min before breakfast
Drug Classification:Anti-infective

MECHANISM INDICATIONS CONTRA- ADVERSE NURSING

INDICATIONS REACTION Responsibilities
Unknown. > Actively - > peripheral >Use
Appears to growing Contraindicate neuropathy, cautiously in
inhibit cell- tubercle bacilli d in patients fluid elderly
wall >prevention of with acute discoloration, patients
biosynthesis tubercle bacilli hepatic disease optic neuritis, >peripheral
by in those or isoniazid- hepatitis neuropathy is
interfering exposed to related liver more
with lipid tuberculosis damge common in
and DNA or those with patients who
synthesis positive skin are slow
test results acetylators or
whose chest who are
x-rays and malnourished,
bacteriologic alcoholic or
studies are diabetic,
consistent >Monitor
with non- hepatic
progressive function
tuberculosis closely for
changes
GENERIC NAME: ketorolac tromethamine
Brand name:Toradol
Dosage: 30 mg Iv q8h
Drug Classification: NSAIDS

MECHANISM INDICATIONS CONTRA- ADVERSE NURSING

INDICATIONS REACTION Responsibilities
Unknown. > short-term - > drowsiness, > Ketorolac
Produces management Contraindicate sedation, isn’t
anti- of moderately d in patients edema, recommended
inflammatory, severe, acute hypersensitive hypertension, for children
analgesic, pain for single to drug and in diarrhea, > Use
and dose those with stomatitis, cautiously in
antipyretic treatment active peptic peptic patients with
effects, > Short-term ulcer disease , ulceration, hepatic and
possibly by management recent GI rash, renal
inhibiting of moderately bleeding or diaphoresis impairment
prostaglandi sever, acute perforation, >NSAIDS may
n synthesis pain for advanced renal mask signs
multiple dose impairment, and
treatment incomplete symptoms of
homeostasis infection
and with high because of
risk of their
bleeding. antipyretic
and anti-
inflammatory
actions
GENERIC NAME: ciprofloxacin
Brand name: Ciprobay
Dosage: 500mg/cap BIDx5 days
Drug Classification: Fluoroquinolones

MECHANISM INDICATIONS CONTRA- ADVERSE NURSING

INDICATIONS REACTION Responsibilities
Inhibits > Severe or - > headache, > Use
bacterial dna complicated Contraindicated retlessness, cautiously in
synthesis, bone or joint to patients fatigue, patients with
mainly by infections sensitive to drowsiness, CNS disorders,
blocking >Complicated fluoroquinolone edema, such as severe
DNA gyrase, intraabdominal s chest pain, cerebral
bactericidal. infections nausea, arteriosclerosis
diarrhea, or seizure
leucopenia, disorders, and
crystalluria in those with
risk for
seizures.
> Monitor
patients intake
and output and
observe for
signs of
crystalluria
>Obtain
specimen for
culture and
sensitivity
before giving
first-dose